Trial intelligence / Profile preview

Metformin for Antipsychotic-induced Metabolic Syndrome in Bipolar Disorder

NCT02644577Phase 4Completed

Sponsor
China Medical University
Start
Jun 2012
Primary completion
Sep 2015
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of metformin in metabolic syndrome, sponsored by China Medical University. Started Jun 2012; status: completed.

02

Drugs

metformin
03

Conditions

metabolic syndrome

Beyond the preview

Go deeper on NCT02644577.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02644577.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call